Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates.

Yoneyama T, Gorry M, Miller MA, Gaither-Davis A, Lin Y, Moss ML, Griffith LG, Lauffenburger DA, Stabile LP, Herman JG, Vujanovic NL.

J Cancer. 2017 Oct 23;8(19):3916-3932. doi: 10.7150/jca.20779. eCollection 2017.

2.

Soluble TNF Regulates TACE via AP-2α Transcription Factor in Mouse Dendritic Cells.

Ge L, Vujanovic NL.

J Immunol. 2017 Jan 1;198(1):417-427. Epub 2016 Nov 16.

3.

Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice.

Sobo-Vujanovic A, Vujanovic L, DeLeo AB, Concha-Benavente F, Ferris RL, Lin Y, Vujanovic NL.

Cancer Immunol Res. 2016 May;4(5):441-51. doi: 10.1158/2326-6066.CIR-15-0104. Epub 2016 Feb 19.

4.

Dendritic-cell exosomes cross-present Toll-like receptor-ligands and activate bystander dendritic cells.

Sobo-Vujanovic A, Munich S, Vujanovic NL.

Cell Immunol. 2014 May-Jun;289(1-2):119-27. doi: 10.1016/j.cellimm.2014.03.016. Epub 2014 Apr 8.

5.

Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands.

Munich S, Sobo-Vujanovic A, Buchser WJ, Beer-Stolz D, Vujanovic NL.

Oncoimmunology. 2012 Oct 1;1(7):1074-1083.

6.

Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10.

Vujanovic L, Ballard W, Thorne SH, Vujanovic NL, Butterfield LH.

Oncoimmunology. 2012 Jul 1;1(4):448-457.

7.

Suppression of natural killer-cell and dendritic-cell apoptotic tumoricidal activity in patients with head and neck cancer.

Baskic D, Vujanovic L, Arsenijevic N, Whiteside TL, Myers EN, Vujanovic NL.

Head Neck. 2013 Mar;35(3):388-98. doi: 10.1002/hed.22968. Epub 2012 Apr 5.

8.

Acupuncture May Stimulate Anticancer Immunity via Activation of Natural Killer Cells.

Johnston MF, Ortiz Sánchez E, Vujanovic NL, Li W.

Evid Based Complement Alternat Med. 2011;2011:481625. doi: 10.1093/ecam/nep236. Epub 2011 Mar 10.

9.

Role of TNF superfamily ligands in innate immunity.

Vujanovic NL.

Immunol Res. 2011 Aug;50(2-3):159-74. doi: 10.1007/s12026-011-8228-8. Review.

PMID:
21717067
10.

Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15.

Vujanovic L, Szymkowski DE, Alber S, Watkins SC, Vujanovic NL, Butterfield LH.

Blood. 2010 Jul 29;116(4):575-83. doi: 10.1182/blood-2009-08-240325. Epub 2010 Apr 29.

11.

Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.

Ge L, Baskic D, Basse P, Vujanovic L, Unlu S, Yoneyama T, Vujanovic A, Han J, Bankovic D, Szczepanski MJ, Hunt JL, Herberman RB, Gollin SM, Ferris RL, Whiteside TL, Myers EN, Vujanovic NL.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2913-22. doi: 10.1158/1055-9965.EPI-08-0898. Epub 2009 Oct 20.

12.

The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation.

Tian F, Grimaldo S, Fujita M, Cutts J, Vujanovic NL, Li LY.

J Immunol. 2007 Sep 15;179(6):3742-51. Erratum in: J Immunol. 2007 Nov 1;179(9):6369. Fugita, Mitsugu [corrected to Fujita, Mitsugu].

13.

Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk.

Xu J, Chakrabarti AK, Tan JL, Ge L, Gambotto A, Vujanovic NL.

Blood. 2007 Apr 15;109(8):3333-41. Epub 2006 Dec 12.

14.

Dendritic cells and natural killer cells interact via multiple TNF family molecules.

Makarenkova V, Chakrabarti AK, Liberatore JA, Popovic P, Lu G, Watkins S, Vujanovic NL.

J Leukoc Biol. 2005 Mar;77(3):408-13. Epub 2004 Dec 16.

PMID:
15604121
15.

A novel epitope of N-CAM defines precursors of human adherent NK cells.

Li S, Xu J, Makarenkova VP, Tjandrawan T, Vakkila J, Reichert T, Gooding W, Lagenaur CF, Achim CL, Chambers WH, Herberman RB, Whiteside TL, Vujanovic NL.

J Leukoc Biol. 2004 Dec;76(6):1187-99. Epub 2004 Sep 8.

PMID:
15356097
16.

Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.

Tatsumi T, Huang J, Gooding WE, Gambotto A, Robbins PD, Vujanovic NL, Alber SM, Watkins SC, Okada H, Storkus WJ.

Cancer Res. 2003 Oct 1;63(19):6378-86.

17.

Role of TNF family ligands in antitumor activity of natural killer cells.

Vujanovic NL.

Int Rev Immunol. 2001 Jun;20(3-4):415-37. Review.

PMID:
11878511
18.
19.

Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway.

Janjic BM, Lu G, Pimenov A, Whiteside TL, Storkus WJ, Vujanovic NL.

J Immunol. 2002 Feb 15;168(4):1823-30.

20.

Blood monocytes and tumor-associated macrophages in human cancer: differences in activation levels.

Baskic D, Acimovic L, Samardzic G, Vujanovic NL, Arsenijevic NN.

Neoplasma. 2001;48(3):169-74.

PMID:
11583284

Supplemental Content

Loading ...
Support Center